ProHealth me-cfs Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Response to vitamin B12 and folic acid in myalgic encephalomyelitis and fibromyalgia.

ADHD (Attention Deficit Hyperactivity Disorder) May Be Common in Fibromyalgia

Be Your Own Researcher: Treat Chronic Pain as a Daily Experiment

You Can Use Mindfulness to Choose How to Live

NEID Disease? Study Suggests Neuro, Endocrine and Immune Systems Work Together to Produce ME/CFS

The Depression Puzzle: Are Anti-inflammatories Better Than Antidepressants? An ME/CFS and FM Perspec...

“WWJD?”

Improvement of severe myalgic encephalomyelitis/chronic fatigue syndrome symptoms following surgical...

Eukaryotes in the gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome

Elevated brain natriuretic peptide levels in chronic fatigue syndrome associate with cardiac dysfunc...

 
Print Page
Email Article

Part of Hutchins $10M goes to Columbia CFS infectious causes study

  [ 10 votes ]   [ Discuss This Article ]
www.ProHealth.com • September 29, 2011


Recently established by a donation of more than $10 million from the Hutchins Family Foundation, the privately funded Chronic Fatigue Initiative (CFInitiative.org) is wasting no time bringing together experts from the world's leading medical research institutions - including Columbia, Harvard, Stanford and Duke Universities – to study the pathogenesis of chronic fatigue syndrome (ME/CFS).

The Initiative's initial phase of funding includes:

• Establishment at NewYork-Presbyterian Hospital/Columbia University Medical Center of the Hutchins Family Fellowship in Infectious Disease, under the direction of Scott Hammer, MD, professor of epidemiology and chief of the Division of Infectious Diseases at NewYork-Presbyterian/Columbia Medical Center.

• And, as announced on Sep 27, a "substantial grant" that establishes a CFS Pathogen Discovery and Pathogenesis Program at Columbia’s Mailman School of Public Health.

The pathogenesis program will leverage the expertise of Columbia’s Center for Infection and Immunity, and will be led by CII director Ian Lipkin, MD, and CII translational research director Mady Hornig, MD.

"Dr. Hornig was the prime mover in designing the research plan and will be shepherding the CFI's research at the Center for Infection and Immunity," says Dr. Lipkin.

Specifically, Dr. Hornig will direct research on CFS biomarkers and pathogen discovery, with a focus on characterizing the causes of this enigmatic disorder.

• Scientists will examine samples from 200 patients and controls using state-of-the-art molecular techniques pioneered at CII. Patients will be recruited across the country from five clinical sites that specialize in chronic fatigue syndrome.

• During the first part of the project, they will screen for already known pathogens thought to be associated with the disease.

• Then they will use unbiased genetic sequencing to help them identify any novel pathogens.

• CII scientists will also look at patients' host response profiles - the immune molecule and antibody signatures in their peripheral blood samples. This will enable researchers to get a comprehensive picture of what is happening in individual patients in relation to pathogens to which they may have been exposed and could lead to the identification of biomarkers for CFS.

Drs. Lipkin and Hornig will collaborate with the Hutchins Family Fellowship program, working with Dr. Hammer and Dr. Claire Gordon, the first Hutchins Family Fellow for Infectious Disease.

"This is a truly exciting opportunity to understand the causes of this often neglected disorder," says Dr. Hornig. "We hope our findings will lead to better diagnoses and the development of an effective treatment."

Source: Columbia University Mailman School of Public Health news releae, Sep 27, 2011




Post a Comment

Featured Products From the ProHealth Store
B-12 Extreme™ MitoQ® Mitochondria Ignite™ with NT Factor®


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Hydroxocobalamin Extreme™ Hydroxocobalamin Extreme™
The B-12 Your Brain Needs for Detox & Sharpness
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
B-12 Extreme™ B-12 Extreme™
The Most Potent Vitamin B-12 on Earth
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get Energized with Malic Acid & Magnesium

Natural Remedies

Nutrients to Combat the Modern Stress Epidemic Nutrients to Combat the Modern Stress Epidemic
Carry a Massage Therapist in Your Pocket Carry a Massage Therapist in Your Pocket
Looking for Energy? Turn to Plants. Looking for Energy? Turn to Plants.
Cocoa's Polyphenol Riches - All the Health Benefits without the Sugar, Calories or Guilt Cocoa's Polyphenol Riches - All the Health Benefits without the Sugar, Calories or Guilt
Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2018 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map